NIFTY 50

Indian cancer patients may get access to CAR T-cell therapy in 8 months, says Dr Siddhartha Mukherjee

Updated : September 16, 2019 07:30 PM IST

A company formed by Mukherjee, Shaw and Kush Parmar plans to pioneer care delivery models at a much lesser cost.
CAR T-cells is derived from your own body and is engineered or weaponised to go and kill cancer cells in your body.
Published : September 16, 2019 02:26 PM IST

You May Also Like

Live TV

recommended for you